Evidence map›Paper›PMID 28553959›Full record

ArticleNature genetics2017

Biallelic TRIP13 mutations predispose to Wilms tumor and chromosome missegregation.

Shawn Yost, Bas de Wolf, Sandra Hanks, Anna Zachariou, Chiara Marcozzi, Matthew Clarke, Richarda de Voer, Banafsheh Etemad, Esther Uijttewaal, Emma Ramsay and 11 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 158 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. RecessiveDiagnostics (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Advances in the genetic etiology of female infertility.Journal of assisted reproduction and genetics · 2024
    Review
  12. Update on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Review
  13. Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Role of TRIP13 in human cancer development.Molecular biology reports · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 3 countries.

Shawn Yost *Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Bas de Wolf *Hubrecht Institute - KNAW (Royal Netherlands Academy of Arts and Sciences), Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Sandra Hanks *Division of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Anna ZachariouDivision of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Chiara MarcozziThe Gurdon Institute and Department of Zoology, University of Cambridge, Cambridge CB2 1QN, UK.
Matthew ClarkeDivision of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Richarda de VoerHubrecht Institute - KNAW (Royal Netherlands Academy of Arts and Sciences), Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Banafsheh EtemadHubrecht Institute - KNAW (Royal Netherlands Academy of Arts and Sciences), Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Esther UijttewaalHubrecht Institute - KNAW (Royal Netherlands Academy of Arts and Sciences), Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Emma RamsayDivision of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Harriet WylieDivision of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Anna ElliottDivision of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Susan PictonChildren's and Adolescent Oncology and Haematology Unit, Leeds General Infirmary, Leeds, LS1 3EX, UK.
Audrey SmithYorkshire Regional Clinical Genetics Service, Chapel Allerton Hospital, Chapeltown Road, Leeds, LS7 4SA, UK.
Sarah SmithsonClinical Genetics Service, St Michael's Hospital, Southwell Street, Bristol, BS2 8EG, UK.
Sheila SealDivision of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Elise RuarkDivision of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Gunnar HougeCenter for Medical Genetics, Haukeland University Hospital, N-5021 Bergen, Norway.
Jonathan PinesThe Gurdon Institute and Department of Zoology, University of Cambridge, Cambridge CB2 1QN, UK.
Geert J P L KopsHubrecht Institute - KNAW (Royal Netherlands Academy of Arts and Sciences), Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
Nazneen RahmanDivision of Genetics and Epidemiology, Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.
Institute of Cancer Research · GBRoyal Netherlands Academy of Arts and Sciences · NLChapel Allerton Hospital · GBHaukeland University Hospital · NOLeeds General Infirmary · GBRoyal Marsden NHS Foundation Trust · GBSt Michael's Hospital · GB

Funding

Wellcome Trust 100210
6 · The paper itself

Abstract

Through exome sequencing, we identified six individuals with biallelic loss-of-function mutations in TRIP13. All six developed Wilms tumor. Constitutional mosaic aneuploidies, microcephaly, developmental delay and seizures, which are features of mosaic variegated aneuploidy (MVA) syndrome, were more variably present. Through functional studies, we show that TRIP13-mutant patient cells have no detectable TRIP13 and have substantial impairment of the spindle assembly checkpoint (SAC), leading to a high rate of chromosome missegregation. Accurate segregation, as well as SAC proficiency, is rescued by restoring TRIP13 function. Individuals with biallelic TRIP13 or BUB1B mutations have a high risk of embryonal tumors, and here we show that their cells display severe SAC impairment. MVA due to biallelic CEP57 mutations, or of unknown cause, is not associated with embryonal tumors and cells from these individuals show minimal SAC deficiency. These data provide insights into the complex relationships between aneuploidy and carcinogenesis.

Indexed as

AneuploidyATPases Associated with Diverse Cellular ActivitiesCarrier ProteinsCell Cycle ProteinsChild, PreschoolChromosome SegregationDevelopmental DisabilitiesDNA, NeoplasmFemaleGenetic Predisposition to DiseaseHumansKidney NeoplasmsLeukemia, Myeloid, AcuteMicrocephalyMicrotubule-Associated ProteinsMosaicismATPases Associated with Diverse Cellular ActivitiesBUB1B protein, humanCarrier ProteinsCell Cycle ProteinsCEP57 protein, humanDNA, NeoplasmMicrotubule-Associated ProteinsNuclear ProteinsProtein Serine-Threonine KinasesTRIP13 protein, human

Identifiers

PMID28553959
PMCPMC5493194
OpenAlexW2619566212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.